UC Staff Senate election opens May 2

Review candidates now to see who is running in the 2022 election

Staff Senate elections run from May 2-13, 2022.  

All UC staff not principally charged with teaching, including part-time and full-time staff, are eligible to vote. Staff will be sent links to the election system when voting is open.

With 91 candidates running for 35 open positions, take the time now to review all candidates as you prepare for voting. While candidates are listed by VP area with the most votes will fill open VP seats, all candidates can be considered for 12 At-Large seats also up for election.

Staff should consider all candidates in all VP areas when casting up to 35 votes in the election.  

Candidates for election received approval from their supervisor to run for Staff Senate with elected senators serving two-year terms. Elected senators attend senate and assigned committee meetings and follow the Staff Senate Bylaws.

The Staff Senate is an advisory body to the UC President and university administration. Staff Senate endeavors to have a duly representative and diverse membership with equitable representation among various colleges, divisions, and departments.

The UC Staff Senate serves the university by promoting, protecting, and representing the interests and perspective of university staff.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.